Your browser is no longer supported. Please, upgrade your browser.
CARA Cara Therapeutics, Inc. daily Stock Chart
Cara Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.52 Insider Own29.45% Shs Outstand32.55M Perf Week-0.71%
Market Cap543.91M Forward P/E- EPS next Y-2.25 Insider Trans5.50% Shs Float29.57M Perf Month4.70%
Income-68.80M PEG- EPS next Q-0.59 Inst Own56.40% Short Float22.77% Perf Quarter3.08%
Sales1.00M P/S543.91 EPS this Y-109.40% Inst Trans26.03% Short Ratio3.21 Perf Half Y63.34%
Book/sh1.07 P/B15.62 EPS next Y4.30% ROA-98.50% Target Price26.88 Perf Year167.36%
Cash/sh1.13 P/C14.78 EPS next 5Y- ROE-117.40% 52W Range4.35 - 20.90 Perf YTD79.87%
Dividend- P/FCF- EPS past 5Y2.40% ROI- 52W High-20.05% Beta3.17
Dividend %- Quick Ratio3.30 Sales past 5Y- Gross Margin- 52W Low284.14% ATR0.93
Employees34 Current Ratio3.30 Sales Q/Q12914.30% Oper. Margin- RSI (14)48.62 Volatility5.11% 6.54%
OptionableYes Debt/Eq0.05 EPS Q/Q-107.40% Profit Margin- Rel Volume0.41 Prev Close16.71
ShortableYes LT Debt/Eq0.05 EarningsMay 04 AMC Payout- Avg Volume2.10M Price16.71
Recom1.60 SMA203.97% SMA50-0.65% SMA20042.06% Volume853,483 Change0.00%
Mar-28-17Reiterated Laidlaw Buy $20 → $35
Mar-28-17Reiterated H.C. Wainwright Buy $22 → $30
Mar-10-17Reiterated Laidlaw Buy $17 → $20
Oct-13-16Initiated H.C. Wainwright Buy $20
Aug-08-16Reiterated Needham Buy $27 → $23
Feb-29-16Reiterated Laidlaw Buy $30 → $17
Nov-04-15Initiated Cantor Fitzgerald Buy
Jul-24-15Reiterated Needham Buy $22 → $27
Mar-03-15Initiated MLV & Co Buy $26
Jan-09-15Initiated Canaccord Genuity Buy $20
Dec-09-14Initiated Summer Street Research Buy $20
Feb-27-14Initiated Needham Buy $27
Feb-25-14Initiated Stifel Buy $21
Feb-25-14Initiated Canaccord Genuity Buy $25
May-26-17 10:24AM  Better Know a Marijuana Stock: Cara Therapeutics Motley Fool
08:27AM  CARA Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CARA-US : May 26, 2017 Capital Cube
May-23-17 01:19PM  Harry Boxer: Four stocks locked in a strong uptrend MarketWatch
May-22-17 01:26PM  ETFs with exposure to CARA Therapeutics, Inc. : May 22, 2017 Capital Cube
May-18-17 08:31AM  The Best- and Worst-Performing Marijuana Stocks Last Week Motley Fool +8.08%
May-17-17 08:00AM  Cara Therapeutics to Present at the 17th Annual Conference on Pain Therapeutics GlobeNewswire -7.20%
May-15-17 04:31PM  3 Biotech Stocks I'd Buy Right Now Motley Fool
08:19AM  CARA Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CARA-US : May 15, 2017 Capital Cube
May-12-17 04:01PM  Cara Therapeutics to Host KOL Meeting on Chronic Kidney Disease-Associated Pruritus on May 16, 2017 GlobeNewswire +7.44%
02:42PM  Why You're Smart to Buy Cara Therapeutics Stock Motley Fool
May-11-17 04:19PM  ETFs with exposure to CARA Therapeutics, Inc. : May 11, 2017 Capital Cube
May-09-17 12:05PM  CARA Therapeutics, Inc. :CARA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-06-17 08:22AM  Why Did Cara Therapeutics Shares Tumble 13.6% in April? Motley Fool
May-04-17 04:06PM  Cara reports 1Q loss Associated Press -6.16%
04:01PM  Cara Therapeutics Reports First Quarter 2017 Financial Results GlobeNewswire
11:00AM  Investor Network: Cara Therapeutics Inc to Host Earnings Call Accesswire
May-01-17 08:32AM  Which Marijuana Stock Will Be Next to Reach a $1 Billion Valuation? Motley Fool
Apr-27-17 08:00AM  Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017 GlobeNewswire
Apr-25-17 04:06PM  CARA Therapeutics, Inc. Value Analysis (NASDAQ:CARA) : April 25, 2017 Capital Cube
Apr-24-17 02:19PM  ETFs with exposure to CARA Therapeutics, Inc. : April 24, 2017 Capital Cube
08:40AM  CARA Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CARA-US : April 24, 2017 Capital Cube
07:00AM  Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety of I.V. CR845 GlobeNewswire
Apr-19-17 09:43AM  Is Cara Therapeutics About to Change How We Treat Pain? Motley Fool
Apr-18-17 07:30AM  Today's Research Reports on Biotech Stocks to Watch: Cara Therapeutics and Incyte Accesswire
07:24AM  Can Drugmakers Cure the Opioid Crisis? Motley Fool
Apr-17-17 08:20AM  Yikes! These 5 Marijuana Stocks Lost a Combined $193 Million in 2016 Motley Fool
Apr-10-17 08:25AM  5 Drug-Developing Marijuana Stocks You Need to Know Motley Fool
Apr-09-17 07:43AM  3 Marijuana Stocks to Buy if You're Leery of Buying Marijuana Stocks Motley Fool
Apr-05-17 06:59PM  Cramer Remix: Best way for you to play the turn in Europe CNBC
04:01PM  Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
02:08PM  5 Stocks Insiders Are Loading Up On
12:21PM  Here's Why Hopeful Marijuana Stock Cara Therapeutics Surged 15% in March Motley Fool
Apr-03-17 05:29PM  CARA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:30AM  Today's Research Reports on Biotech Stocks to Watch: Bioline RX and Cara Therapeutics Accesswire
Mar-31-17 03:05PM  Cara Therapeutics Is Scratching the Itch for Promising Biotechs Motley Fool
01:39PM  Cara Therapeutics Ends Mixed Month With Upgrade From Vetr Crowd Benzinga
11:00AM  Cara Therapeutics Announces Pricing for Secondary Offering 24/7 Wall St.
Mar-30-17 09:35PM  Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock GlobeNewswire -7.36%
04:42PM  3 Revolutionary Drugs for Chronic Pain Motley Fool
10:33AM  5 Top Performing Stocks of the Best ETF of Q1
09:23AM  Western Digital, Nektar Therapeutics And Two More Stocks Breaking Out
Mar-29-17 04:01PM  Cara Therapeutics Announces Proposed Offering of Common Stock GlobeNewswire +6.08%
02:10PM  Harry Boxers five technology and biotechnology stocks to watch at MarketWatch
09:10AM  Cara Therapeutics (CARA) Shows Strength: Stock Up 5.2%
09:10AM  Cara Therapeutics (CARA) Shows Strength: Stock Up 5.2% at Investopedia
08:15AM  Blog Coverage Cara Therapeutics Reported Positive Top-line Results Accesswire
Mar-28-17 05:41PM  Cara Therapeutics Delivers Important Win at Motley Fool +5.18%
04:53PM  Here's Why Cara Therapeutics Rose as Much as 11.5% Today at Motley Fool
04:30PM  Cara Therapeutics to Webcast Presentation at the 16th Annual Needham Healthcare Conference GlobeNewswire
03:02PM  Cara Therapeutics Powering to Key Resistance Levels at Investopedia
12:36PM  Caras Kidney Drug Succeeds in Mid-Stage Study at Investopedia
09:30AM  Biotech Coverage After the Collapse of Trumpcare: Today's Research Reports on Cara Therapeutics and Corbus Pharmaceuticals Accesswire
09:00AM  CARA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:25AM  Cara Therapeutics shares surge 16% on positive results in trial of UP treatment at MarketWatch
07:00AM  Cara Therapeutics Announces Positive Top-Line Data From Part A of Phase 2/3 Trial of I.V. CR845 in Chronic Kidney Disease-Associated Pruritus GlobeNewswire
Mar-27-17 03:51PM  ETFs with exposure to CARA Therapeutics, Inc. : March 27, 2017 +8.29%
Mar-24-17 12:00PM  3 Hot Biotech Stocks Now at Motley Fool
Mar-22-17 12:43PM  4 Biotech Stocks to Watch
Mar-21-17 08:09AM  4 Biotech Stocks With Jaw-Dropping Growth Potential at Motley Fool
Mar-17-17 09:33AM  5 Biotech Companies To Watch In 2017
07:30AM  5 Biotech Companies Set for Major Breakouts In 2017
07:20AM  What Makes Cara Therapeutics So Intriguing? at Motley Fool
Mar-16-17 01:04PM  CARA THERAPEUTICS, INC. Financials
Mar-14-17 02:32PM  CARA Therapeutics, Inc. :CARA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
01:39PM  Marijuana Stocks: Sean Williams, GW Pharmaceuticals PLC- ADR (GWPH), And Cara Therapeutics Inc (CARA) at Insider Monkey
08:02AM  3 Biotech Stock Rockets With More Fuel in the Tank at Motley Fool
Mar-13-17 04:30PM  Cara Therapeutics to Present at March Medical Meetings GlobeNewswire
Mar-10-17 04:58PM  Falling Biotechs: Cara Reports Zero Sales, Ionis Downgraded -9.43%
03:26PM  Here's Why Shares of Hopeful Marijuana Stock Cara Therapeutics Inc. Went Up in Smoke at Motley Fool
02:27PM  Cara Therapeutics Reports Q4 Loss (CARA) at Investopedia
08:33AM  Are Options Traders Betting on a Big Move in Cara Therapeutics, Inc. (CARA) Stock?
07:14AM  CARA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
Mar-09-17 04:52PM  Cara reports 4Q loss
04:12PM  CARA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
04:01PM  Cara Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
09:30AM  Today's Research Reports on Trending Biotech Tickers: Peregrine Pharmaceuticals and Cara Therapeutics Accesswire
07:07AM  Q4 2016 Cara Therapeutics Inc Earnings Release - After Market Close
Mar-07-17 03:49PM  Forget Cara Therapeutics' Earnings: Here's the Real Reason Its Stock Could Soar This Quarter at Motley Fool -5.19%
Mar-03-17 11:54AM  Market Action Is Boring but Necessary +7.64%
Mar-02-17 11:15AM  Shark Bites: Market Taking a Break, but Probably Not for Long
08:00AM  Cara Therapeutics to Announce Fourth Quarter and Full Year 2016 Financial Results on March 9, 2017 GlobeNewswire
Mar-01-17 11:10AM  3 Growth Stocks That Could Soar More Than Nvidia at Motley Fool
Feb-17-17 11:11AM  3 Biotech Stocks to Buy in February at Motley Fool
Feb-15-17 09:05AM  Here's What 'Superinvestors' Are Doing During the Latest Surge in the Stock Market
Feb-13-17 03:15PM  Why Shares of Cara Therapeutics Are Up Over 75% Since the Start of 2017 at Motley Fool -9.02%
02:36PM  How High Can Cara Therapeutics Stock Go? at Motley Fool
Feb-09-17 07:37AM  What Will Jeff Sessions Mean for the Marijuana Industry? at Investopedia
Feb-08-17 02:26PM  Why Cara Therapeutics Stock Gained 57% in January at Motley Fool
Feb-03-17 08:14AM  Harry Boxer: Watch these two biotechnology stocks at MarketWatch +5.11%
Feb-02-17 05:13PM  AMD Shows Strength, Weakness Continues For Carter's at Forbes
Feb-01-17 08:35AM  Cara Therapeutics (CARA) Worth Watching: Stock Jumps 8% +7.64%
Jan-27-17 10:00AM  Biotech M&A Activity Expected to Rise in 2017: Latest Reports on Pulmatrix and Cara Therapeutics Accesswire
Jan-25-17 02:09PM  Cannabis Stocks Do Not Trade on Earnings, Instead on Pipeline of Drugs +5.72%
Jan-22-17 08:27AM  This Little Biotech Could Have a Big Winner on Its Hands at Motley Fool
Jan-18-17 11:29AM  Top 4 Medicinal Marijuana Stocks for 2017 at Investopedia +6.26%
Jan-15-17 03:44PM  Donald Trump On Weed Legalization: Whats In Store For Marijuana Stocks? at Insider Monkey
Jan-12-17 09:37AM  12 Health Benefits of Medical Marijuana According To Publicly Traded Weed Companies at Insider Monkey
Jan-11-17 12:37PM  ETFs with exposure to CARA Therapeutics, Inc. : January 11, 2017
Jan-06-17 10:55AM  Healthcare Stocks to Buy for 2017: Less Risky, More Risky, and Most Risky at Motley Fool
Dec-30-16 01:36PM  The 2016 Election Was A Tipping Point For Marijuana Stocks at Forbes
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. It is developing product candidates that target the body's peripheral nervous system. The company's lead product candidate comprises I.V. CR845, which is in Phase III clinical trials for the treatment of patients with acute postoperative pain in adult patients, as well as in Phase II/III clinical trial for the treatment of uremic pruritus disease. It is also developing Oral CR845 that is in Phase IIb clinical trial to treat moderate-to-severe acute and chronic pain, as well as in Phase I clinical trial to treat uremic pruritus; and CR701, which is in preclinical trial for the treatment of neuropathic and inflammatory pain. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing CR845 for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing CR845 in South Korea. Cara Therapeutics, Inc. was founded in 2004 and is headquartered in Stamford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RHO Ventures VI LP10% OwnerMar 31Buy18.19500,0009,095,7003,568,057Apr 03 09:19 AM